Open Insider Trading Activity for Alnylam Pharmaceuticals, Inc. CSO & EVP, Head of Research Fitzgerald Kevin Joseph
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction ALNY | 2026-03-06 | 2026-03-05 | Alnylam Pharmaceuticals, Inc. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | 12 | 1,291 | $323.54 | $417,685.48 | 0.50% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ALNY | 2026-02-17 | 2026-02-17 | Alnylam Pharmaceuticals, Inc. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | 2 | 4,000 | $321.24 | $1,284,977.08 | 8.24% | View Filing |